<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Nonimmune hydrops fetalis in the neonate: Causes, presentation, and overview of neonatal management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Nonimmune hydrops fetalis in the neonate: Causes, presentation, and overview of neonatal management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Nonimmune hydrops fetalis in the neonate: Causes, presentation, and overview of neonatal management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael E Speer, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard Martin, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carrie Armsby, MD, MPH</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 17, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Hydrops fetalis is a condition of excess fluid accumulation in the fetus. It may result in fetal demise and is associated with considerable risk of neonatal morbidity and mortality. (See <a class="local">'Outcome'</a> below.)</p><p>Hydrops fetalis can be immune-mediated or nonimmune:</p><p class="bulletIndent1"><span class="glyph">●</span>Immune-mediated hydrops fetalis is a result of severe fetal anemia in the setting of alloimmune hemolytic anemia due to Rh incompatibility between the mother and fetus. This is discussed separately. (See  <a class="medical medical_review" href="/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management", section on 'Hydrops fetalis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nonimmune hydrops fetalis (NHF) is associated with numerous disorders that include cardiac, pulmonary, infectious, and genetic etiologies  (<a class="graphic graphic_table graphicRef70066" href="/d/graphic/70066.html" rel="external">table 1</a>). In the modern era, NHF accounts for almost 90 percent of hydropic cases in neonates.</p><p></p><p>This topic will discuss the causes and presentation of NHF and will provide an overview of the initial management of a newborn with NHF. Other related topics include:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6820.html" rel="external">"RhD alloimmunization in pregnancy: Overview"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6802.html" rel="external">"RhD alloimmunization in pregnancy: Management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/6773.html" rel="external">"RhD alloimmunization: Prevention in pregnant and postpartum patients"</a>.)</p><p></p><p class="headingAnchor" id="H3"><span class="h1">EPIDEMIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nonimmune hydrops fetalis</strong> – Nonimmune hydrops fetalis (NHF) is uncommon, with an estimated prevalence of approximately 2 to 3 cases per 10,000 live births [<a href="#rid1">1</a>]. There is some variation depending on the prevalence of certain genetic conditions in the population (eg, increased incidence of alpha thalassemia in Southeast Asia) and whether late pregnancy terminations were included in the analysis. The epidemiology of NHF is discussed in greater detail separately. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Prevalence'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Immune-mediated hydrops fetalis</strong> – In high-resource countries, the incidence of immune-mediated hydrops fetalis has dramatically declined since the 1970s due to the implementation of antenatal Rh(D) <a class="drug drug_pediatric" data-topicid="83878" href="/d/drug information/83878.html" rel="external">immune globulin</a> prophylaxis [<a href="#rid2">2,3</a>]. However, in some parts of the world, immune causes remain a significant cause of hydrops fetalis [<a href="#rid4">4</a>]. This is discussed separately. (See  <a class="medical medical_review" href="/d/html/6820.html" rel="external">"RhD alloimmunization in pregnancy: Overview"</a>.)</p><p></p><p class="headingAnchor" id="H3560032357"><span class="h1">CAUSES</span><span class="headingEndMark"> — </span>Causes of nonimmune hydrops fetalis (NHF) are summarized in the table  (<a class="graphic graphic_table graphicRef70066" href="/d/graphic/70066.html" rel="external">table 1</a>) [<a href="#rid3">3,5-9</a>]. </p><p>In a systematic review that included &gt;1300 neonates with NHF, the relative frequencies of various underlying causes were as follows [<a href="#rid5">5</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Cardiovascular disease, including structural congenital heart disease and congenital arrythmias (20 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Lymphatic dysplasia (15 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Hematologic diseases (eg, alpha thalassemia) (9 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Chromosomal abnormalities (9 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Infections (7 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Syndromic causes without a known genetic defect (6 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Twin-to-twin transfusions and placental vascular abnormalities (4 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Thoracic malformations (2 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Inborn error of metabolism (1 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Congenital anomalies of the kidney and urinary tract (1 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Thoracic tumors (1 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Miscellaneous (4 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Idiopathic (20 percent)</p><p></p><p>A more detailed discussion of the etiologies of NHF is provided separately. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Etiology and prenatal management of disorders associated with hydrops'</a>.)</p><p class="headingAnchor" id="H4"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Understanding the basic mechanisms that underlie the development of hydrops fetalis is important in directing both antenatal and postnatal treatment of hydrops fetalis.</p><p>Normally, the formation of interstitial fluid from the vascular space is balanced by the return of interstitial fluid back to the central venous system through the lymphatic system. The process is governed by Starling's Law and is dependent upon the four following components:</p><p class="bulletIndent1"><span class="glyph">●</span>Capillary hydrostatic pressure</p><p class="bulletIndent1"><span class="glyph">●</span>Capillary oncotic pressure</p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial hydrostatic pressure</p><p class="bulletIndent1"><span class="glyph">●</span>Interstitial osmotic pressure, which is dependent on lymphatic return</p><p></p><p>The fetus is particularly vulnerable to increased interstitial fluid accumulation because of its greater capillary permeability, compliant interstitial compartments, and increased susceptibility to impaired lymphatic flow.</p><p>In cases of hydrops fetalis, accumulation of interstitial fluid occurs because the production of interstitial fluid greatly exceeds the lymphatic return. Although the pathogenesis is not clearly understood, hydrops fetalis appears to be multifactorial due to mechanisms that produce elevated central venous pressure, impair lymphatic return, and increase capillary leakage.</p><p class="headingAnchor" id="H5"><span class="h2">Elevated venous pressure</span><span class="headingEndMark"> — </span>Elevated central venous pressure (CVP) increases capillary hydrostatic pressure and impairs lymphatic return to the vascular space [<a href="#rid10">10,11</a>].</p><p>Both low (eg, cardiac arrhythmia, congenital structural heart disease, and myocarditis) and high-output cardiac failure (eg, severe anemia, arterial-venous malformations, and twin-twin transfusion syndrome) cause elevated CVP that may result in hydrops fetalis [<a href="#rid3">3,12-20</a>]. Elevation of CVP appears to be a critical component in the pathogenesis of hydrops fetalis because animal studies have demonstrated that severe anemia alone does not cause hydrops fetalis, but rather only causes hydrops fetalis in the presence of increased CVP [<a href="#rid21">21,22</a>].</p><p>CVP elevation may also be caused by obstruction of either the superior and/or inferior vena cavas as demonstrated in cases of congenital cystic adenomatoid malformation, omphalocele, cervical or mediastinal teratoma, or congenital high airway obstruction syndrome [<a href="#rid23">23-27</a>]. Compression of the vascular system impedes lymphatic return and results in edema formation.</p><p class="headingAnchor" id="H6"><span class="h2">Impaired lymphatic drainage</span><span class="headingEndMark"> — </span>Lymph return to the central venous system is reduced either by structural abnormality or, as previously discussed, by functional impairment due to increased CVP.</p><p>Anomalous development results in structural dysgenesis of the lymphatic network and is seen in the following conditions: chylothorax, cervical hygroma, congenital lymphedema, and cystic lymphangiectasia [<a href="#rid3">3,28-31</a>]. These structural anomalies are often associated with chromosomal abnormalities, such as Turner syndrome [<a href="#rid32">32</a>]. (See  <a class="medical medical_review" href="/d/html/435.html" rel="external">"Enlarged nuchal translucency and cystic hygroma"</a>.)</p><p class="headingAnchor" id="H7"><span class="h2">Capillary oncotic pressure</span><span class="headingEndMark"> — </span>In theory, reduced capillary oncotic pressure should contribute to hydrops fetalis. However, data from animal studies demonstrated that hypoproteinemia does not result in nonimmune hydrops fetalis (NHF) [<a href="#rid33">33</a>].</p><p class="headingAnchor" id="H8"><span class="h2">Hypoxia</span><span class="headingEndMark"> — </span>Animal studies have shown that severe fetal hypoxia causes hydrops fetalis. In these studies, there is sustained activation of the renin-angiotensin system with elevation of renin in the absence of renal injury or elevation of CVP [<a href="#rid34">34,35</a>]. In addition, hypoxia results in endothelial injury and interferes with nitric oxide and cyclic guanosine monophosphate production [<a href="#rid36">36,37</a>], which may increase capillary leakage, resulting in greater movement of fluid from the vascular to the interstitial space.</p><p class="headingAnchor" id="H724487904"><span class="h1">PRESENTATION</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prenatal diagnosis and evaluation</strong> – Most cases of nonimmune hydrops fetalis (NHF) are diagnosed prenatally with ultrasonography. Prenatal detection of NHF and the subsequent evaluation are discussed separately. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Postdiagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postnatal findings</strong> – Findings at birth in the newborn may include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Skin edema</p><p class="bulletIndent2"><span class="glyph">•</span>Pleural effusion</p><p class="bulletIndent2"><span class="glyph">•</span>Pericardial effusion</p><p class="bulletIndent2"><span class="glyph">•</span>Ascites</p><p class="bulletIndent2"><span class="glyph">•</span>Respiratory distress</p><p class="bulletIndent2"><span class="glyph">•</span>Circulatory collapse or shock</p><p></p><p class="headingAnchor" id="H9"><span class="h1">OVERVIEW OF INITIAL NEONATAL MANAGEMENT</span></p><p class="headingAnchor" id="H10"><span class="h2">Delivery room care</span><span class="headingEndMark"> — </span>Delivery room care requires close collaboration between the obstetric and neonatal teams. Whenever possible, delivery should occur at a center with a level III neonatal intensive care unit where the required resources are available (neonatal resuscitation team, mechanical ventilatory support, exchange transfusion, pediatric surgery). </p><p>Resuscitation in the delivery room should proceed according to standard guidelines, as summarized in the figure  (<a class="graphic graphic_algorithm graphicRef140126" href="/d/graphic/140126.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5015.html" rel="external">"Neonatal resuscitation in the delivery room"</a>.)</p><p>The neonatal team should anticipate any special needs of the newborn based upon the prenatal evaluation. For example:</p><p class="bulletIndent1"><span class="glyph">●</span>Preparation should anticipate the possible need to drain fluid if there are symptomatic pleural effusions. (See  <a class="medical medical_review" href="/d/html/88437.html" rel="external">"Approach to the neonate with pleural effusions", section on 'Thoracocentesis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If severe anemia is anticipated, unmatched type O, RhD-negative packed red blood cells should be available. (See  <a class="medical medical_review" href="/d/html/5041.html" rel="external">"Red blood cell (RBC) transfusions in the neonate", section on 'Use of O-negative blood'</a>.)</p><p></p><p class="headingAnchor" id="H1795011630"><span class="h2">Subsequent care</span></p><p class="headingAnchor" id="H4041604059"><span class="h3">General supportive measures</span><span class="headingEndMark"> — </span>General supportive care for the hydropic infant includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Providing respiratory support as needed. Many affected infants require intubation and mechanical ventilation. (See  <a class="medical medical_review" href="/d/html/5067.html" rel="external">"Respiratory support, oxygen delivery, and oxygen monitoring in the newborn"</a> and  <a class="medical medical_review" href="/d/html/5032.html" rel="external">"Overview of mechanical ventilation in neonates"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Red blood cell transfusion if the neonate has severe anemia. This can usually be accomplished with a simple transfusion administered cautiously. However, neonates with long-standing in-utero anemia (eg, twin-twin transfusion, chronic fetomaternal hemorrhage) may have elevated circulating blood volume and evidence of high-output heart failure. Such patients may tolerate partial exchange transfusion better than simple transfusion. (See  <a class="medical medical_review" href="/d/html/5041.html" rel="external">"Red blood cell (RBC) transfusions in the neonate"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hemodynamic support if the neonate has signs of shock. (See  <a class="medical medical_review" href="/d/html/126605.html" rel="external">"Neonatal shock: Management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Drainage of significant symptomatic fluid collections (eg, pleural effusion, ascites). (See  <a class="medical medical_review" href="/d/html/88437.html" rel="external">"Approach to the neonate with pleural effusions", section on 'Thoracocentesis'</a>.)</p><p></p><p class="headingAnchor" id="H1707222908"><span class="h3">Management of the underlying cause</span><span class="headingEndMark"> — </span>In many cases, the underlying cause of hydrops fetalis is identified prenatally and management is directed to the specific cause. Specific causes of hydrops fetalis are discussed in separate topic reviews:</p><p class="bulletIndent1"><span class="glyph">●</span>Structural heart disease (see  <a class="medical medical_review" href="/d/html/5785.html" rel="external">"Diagnosis and initial management of cyanotic heart disease in the newborn", section on 'Initial management'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Fetal arrhythmia or congenital heart block (see  <a class="medical medical_review" href="/d/html/6765.html" rel="external">"Fetal arrhythmias"</a> and  <a class="medical medical_review" href="/d/html/912.html" rel="external">"Congenital third-degree (complete) atrioventricular block"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Alloimmune hemolytic disease of the newborn (see  <a class="medical medical_review" href="/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management", section on 'Postnatal management'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anemia due to nonimmune causes (eg, massive fetomaternal hemorrhage, alpha thalassemia) (see  <a class="medical medical_review" href="/d/html/6806.html" rel="external">"Spontaneous massive fetomaternal hemorrhage"</a> and  <a class="medical medical_review" href="/d/html/131582.html" rel="external">"Alpha thalassemia major: Prenatal and postnatal management", section on 'Management (prenatal and neonatal)'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In utero infections, examples include: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Congenital cytomegalovirus (see  <a class="medical medical_review" href="/d/html/98188.html" rel="external">"Congenital cytomegalovirus infection: Management and outcome"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital toxoplasmosis gondii (see  <a class="medical medical_review" href="/d/html/15835.html" rel="external">"Congenital toxoplasmosis: Treatment, outcome, and prevention"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Parvovirus B19 (see  <a class="medical medical_review" href="/d/html/8281.html" rel="external">"Parvovirus B19 infection during pregnancy"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital syphilis (see  <a class="medical medical_review" href="/d/html/15400.html" rel="external">"Congenital syphilis: Management and outcome"</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Congenital pulmonary and thoracic malformations, examples include:  </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Congenital diaphragmatic hernia (see  <a class="medical medical_review" href="/d/html/4963.html" rel="external">"Congenital diaphragmatic hernia in the neonate"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Bronchopulmonary sequestration (see  <a class="medical medical_review" href="/d/html/6341.html" rel="external">"Bronchopulmonary sequestration"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Congenital pulmonary airway malformation (see  <a class="medical medical_review" href="/d/html/6346.html" rel="external">"Congenital pulmonary airway malformation"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Aneuploidy or structural chromosomal abnormalities, examples include:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Trisomy 21 (Down syndrome) (see  <a class="medical medical_review" href="/d/html/2938.html" rel="external">"Down syndrome: Management"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Trisomy 18 (Edward syndrome) (see  <a class="medical medical_review" href="/d/html/452.html" rel="external">"Congenital cytogenetic abnormalities", section on 'Trisomy 18 syndrome'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Trisomy 13 (see  <a class="medical medical_review" href="/d/html/452.html" rel="external">"Congenital cytogenetic abnormalities", section on 'Trisomy 13 syndrome'</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>45 X (Turner syndrome) (see  <a class="medical medical_review" href="/d/html/7386.html" rel="external">"Management of Turner syndrome in children and adolescents"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Metabolic disorders (eg, Gaucher’s disease, mucopolysaccharidoses) (see  <a class="medical medical_review" href="/d/html/17216.html" rel="external">"Inborn errors of metabolism: Identifying the specific disorder"</a> and  <a class="medical medical_review" href="/d/html/2934.html" rel="external">"Gaucher disease: Treatment"</a> and  <a class="medical medical_review" href="/d/html/113802.html" rel="external">"Mucopolysaccharidoses: Treatment"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Urologic disorders (eg, prune belly syndrome, posterior urethral valves) (see  <a class="medical medical_review" href="/d/html/5002.html" rel="external">"Prune-belly syndrome"</a> and  <a class="medical medical_review" href="/d/html/6574.html" rel="external">"Management of posterior urethral valves"</a>)</p><p></p><p class="headingAnchor" id="H13"><span class="h1">POSTNATAL EVALUATION</span><span class="headingEndMark"> — </span>In many cases, the underlying cause of hydrops fetalis is identified during the prenatal evaluation. The prenatal evaluation is discussed separately. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Postdiagnostic evaluation'</a>.)</p><p>Additional postnatal evaluation may be warranted to identify the underlying cause if it remains uncertain or to better characterize the prenatally diagnosed condition.</p><p>Postnatal evaluation generally includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Pathologic examination of the placenta for evidence of congenital infection, chorioangioma, or other abnormalities [<a href="#rid38">38,39</a>]. (See  <a class="medical medical_review" href="/d/html/5393.html" rel="external">"Gross examination of the placenta"</a> and  <a class="medical medical_review" href="/d/html/2282.html" rel="external">"The placental pathology report"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Detailed physical examination of the newborn to identify any dysmorphisms or clinical findings suggestive of congenital infection  (<a class="graphic graphic_table graphicRef76743" href="/d/graphic/76743.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/d/html/2940.html" rel="external">"Congenital anomalies: Approach to evaluation", section on 'Physical examination'</a> and  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Laboratory tests (including complete blood count, serum electrolytes, kidney function tests, liver function tests, and blood gas) to identify infants with anemia, kidney disease, liver disease, or impaired gas exchange.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Chest radiograph to evaluate for lung abnormalities and pleural effusions. Additional chest imaging may be warranted, depending on the prenatal findings.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cardiac evaluation, including pulse oximetry, electrocardiogram, and echocardiography, to identify an underlying rhythm disorder (arrhythmia, congenital heart block) or structural heart disease). (See  <a class="medical medical_review" href="/d/html/5774.html" rel="external">"Identifying newborns with critical congenital heart disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Genetic evaluation if a genetic syndrome is suspected. This should be performed in consultation with a clinical geneticist. Chromosomal microarray analysis is typically the first-line test, if not performed prenatally [<a href="#rid40">40</a>]. (See  <a class="medical medical_review" href="/d/html/2940.html" rel="external">"Congenital anomalies: Approach to evaluation", section on 'Laboratory studies'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infectious work-up if congenital infection is suspected. (See  <a class="medical medical_review" href="/d/html/6011.html" rel="external">"Overview of TORCH infections", section on 'Approach to the infant with suspected intrauterine infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Evaluation for inborn errors of metabolism if a metabolic disorder is suspected. (See  <a class="medical medical_review" href="/d/html/17216.html" rel="external">"Inborn errors of metabolism: Identifying the specific disorder"</a> and  <a class="medical medical_review" href="/d/html/130068.html" rel="external">"Newborn screening for inborn errors of metabolism"</a>.) </p><p></p><p class="headingAnchor" id="H17"><span class="h1">OUTCOME</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Survival</strong> – Survival depends upon the underlying cause of hydrops fetalis [<a href="#rid3">3</a>]. Overall, the estimated survival (ie, surviving to hospital discharge) among live-born infants with hydrops fetalis is approximately 50 to 60 percent [<a href="#rid3">3,41,42</a>]. </p><p></p><p class="bulletIndent1">In a report of 598 live-born infants with hydrops fetalis, survival was highest for infants with isolated congenital chylothorax (6 percent) and lowest for infants with multiple congenital anomalies (42 percent) [<a href="#rid3">3</a>]. Additional risk factors for mortality included lower gestational age, five-minute Apgar score ≤3, and need for intensive respiratory support (eg, high-frequency ventilation).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurodevelopment outcome —</strong> Approximately 45 to 70 percent of surviving infants have neurodevelopmental impairments, including intellectual disability, learning disabilities, and motor disabilities (eg, cerebral palsy) [<a href="#rid43">43,44</a>]. The risk of disability depends on the underlying cause of hydrops fetalis and other comorbidities. All surviving infants warrant close neurodevelopmental surveillance. (See  <a class="medical medical_review" href="/d/html/615.html" rel="external">"Developmental-behavioral surveillance and screening in primary care"</a>.)</p><p></p><p class="headingAnchor" id="H21"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Causes </strong>– Hydrops fetalis is a condition of excess fluid accumulation in the fetus. It can be immune-mediated or nonimmune:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Immune-mediated hydrops fetalis</strong> results from severe anemia in the setting of alloimmune hemolytic anemia due to Rh incompatibility between the mother and fetus. This is discussed separately. (See  <a class="medical medical_review" href="/d/html/5933.html" rel="external">"Alloimmune hemolytic disease of the newborn: Postnatal diagnosis and management", section on 'Hydrops fetalis'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Nonimmune hydrops fetalis (NHF)</strong> is associated with numerous disorders that include cardiac, pulmonary, infectious, and genetic etiologies. The causes are summarized in the table  (<a class="graphic graphic_table graphicRef70066" href="/d/graphic/70066.html" rel="external">table 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Etiology and prenatal management of disorders associated with hydrops'</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Presentation </strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Prenatal diagnosis and evaluation</strong> – Most cases of NHF are diagnosed prenatally with ultrasonography. Prenatal detection of NHF and the subsequent evaluation are discussed separately. (See  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/6794.html" rel="external">"Nonimmune hydrops fetalis", section on 'Postdiagnostic evaluation'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postnatal findings</strong> – Findings at birth in the newborn may include (see <a class="local">'Presentation'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Skin edema</p><p class="bulletIndent3"><span class="glyph">-</span>Pleural effusion</p><p class="bulletIndent3"><span class="glyph">-</span>Pericardial effusion</p><p class="bulletIndent3"><span class="glyph">-</span>Ascites</p><p class="bulletIndent3"><span class="glyph">-</span>Respiratory distress</p><p class="bulletIndent3"><span class="glyph">-</span>Circulatory collapse or shock</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Delivery room care</strong> – Resuscitation in the delivery room should proceed according to standard guidelines, as summarized in the figure  (<a class="graphic graphic_algorithm graphicRef140126" href="/d/graphic/140126.html" rel="external">algorithm 1</a>) and discussed in detail separately. (See  <a class="medical medical_review" href="/d/html/5015.html" rel="external">"Neonatal resuscitation in the delivery room"</a>.)</p><p></p><p class="bulletIndent1">The neonatal team should anticipate any special needs of the newborn based upon the prenatal evaluation. For example:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Preparation should anticipate the possible need to drain fluid if there are symptomatic pleural effusions (see  <a class="medical medical_review" href="/d/html/88437.html" rel="external">"Approach to the neonate with pleural effusions", section on 'Thoracocentesis'</a>)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If severe anemia is anticipated, unmatched type O, RhD-negative packed red blood cells should be available (see  <a class="medical medical_review" href="/d/html/5041.html" rel="external">"Red blood cell (RBC) transfusions in the neonate", section on 'Use of O-negative blood'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>General supportive measures</strong> – General supportive care for the hydropic infant includes (see <a class="local">'General supportive measures'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Providing respiratory support as needed (see  <a class="medical medical_review" href="/d/html/5067.html" rel="external">"Respiratory support, oxygen delivery, and oxygen monitoring in the newborn"</a> and  <a class="medical medical_review" href="/d/html/5032.html" rel="external">"Overview of mechanical ventilation in neonates"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Red blood cell transfusion if the neonate has severe anemia (see  <a class="medical medical_review" href="/d/html/5041.html" rel="external">"Red blood cell (RBC) transfusions in the neonate"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Hemodynamic support if the neonate has signs of shock (see  <a class="medical medical_review" href="/d/html/126605.html" rel="external">"Neonatal shock: Management"</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Drainage of significant symptomatic fluid collections (eg, pleural effusions) (see  <a class="medical medical_review" href="/d/html/88437.html" rel="external">"Approach to the neonate with pleural effusions", section on 'Thoracocentesis'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of the underlying cause</strong> – In many cases, the underlying cause of hydrops fetalis is identified prenatally and management is directed to the specific cause. (See <a class="local">'Management of the underlying cause'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postnatal evaluation</strong> – A postnatal evaluation is generally warranted to identify the underlying cause if it remains uncertain after the prenatal evaluation or to better characterize the prenatally diagnosed condition. The evaluation includes (see <a class="local">'Postnatal evaluation'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Examination of the placenta </p><p class="bulletIndent2"><span class="glyph">•</span>Detailed physical examination of the newborn to identify any dysmorphisms or clinical findings suggestive of congenital infection  (<a class="graphic graphic_table graphicRef76743" href="/d/graphic/76743.html" rel="external">table 2</a>)</p><p class="bulletIndent2"><span class="glyph">•</span>Laboratory tests, including complete blood count, serum electrolytes, kidney function tests, liver function tests, and blood gas</p><p class="bulletIndent2"><span class="glyph">•</span>Chest radiograph </p><p class="bulletIndent2"><span class="glyph">•</span>Cardiac evaluation, including pulse oximetry, electrocardiogram, and echocardiography</p><p class="bulletIndent2"><span class="glyph">•</span>Genetic evaluation if a genetic syndrome is suspected</p><p class="bulletIndent2"><span class="glyph">•</span>Infectious work-up if congenital infection is suspected</p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation for inborn errors of metabolism if a metabolic disorder is suspected</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcome</strong> – Outcomes for infants with NHF depend on the underlying etiology. In general, affected infants are at high risk of mortality and morbidity, including neurodevelopmental impairment. (See <a class="local">'Outcome'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Steurer MA, Peyvandi S, Baer RJ, et al. Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis-Insights from a Population-Based Dataset. J Pediatr 2017; 187:182.</a></li><li><a class="nounderline abstract_t">Macafee CA, Fortune DW, Beischer NA. Non-immunological hydrops fetalis. J Obstet Gynaecol Br Commonw 1970; 77:226.</a></li><li><a class="nounderline abstract_t">Abrams ME, Meredith KS, Kinnard P, Clark RH. Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death. Pediatrics 2007; 120:84.</a></li><li><a class="nounderline abstract_t">Emiroğlu N, Yılmaz FH, Keçeci R, et al. Clinical characteristics and neonatal outcomes of liveborn newborns with hydrops fetalis treated in a tertiary level neonatal intensive care unit. Birth Defects Res 2020; 112:515.</a></li><li><a class="nounderline abstract_t">Bellini C, Donarini G, Paladini D, et al. Etiology of non-immune hydrops fetalis: An update. Am J Med Genet A 2015; 167A:1082.</a></li><li><a class="nounderline abstract_t">Rodríguez MM, Bruce JH, Jiménez XF, et al. Nonimmune hydrops fetalis in the liveborn: series of 32 autopsies. Pediatr Dev Pathol 2005; 8:369.</a></li><li><a class="nounderline abstract_t">Yang YH, Teng RJ, Tang JR, et al. Etiology and outcome of hydrops fetalis. J Formos Med Assoc 1998; 97:16.</a></li><li><a class="nounderline abstract_t">Liao C, Wei J, Li Q, et al. Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China. Fetal Diagn Ther 2007; 22:302.</a></li><li><a class="nounderline abstract_t">Huang HR, Tsay PK, Chiang MC, et al. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol 2007; 24:33.</a></li><li><a class="nounderline abstract_t">Gest AL, Bair DK, Vander Straten MC. The effect of outflow pressure upon thoracic duct lymph flow rate in fetal sheep. Pediatr Res 1992; 32:585.</a></li><li><a class="nounderline abstract_t">Gest AL, Bair DK, Vander Straten MC. Thoracic duct lymph flow in fetal sheep with increased venous pressure from electrically induced tachycardia. Biol Neonate 1993; 64:325.</a></li><li><a class="nounderline abstract_t">Kanzaki T, Chiba Y. Evaluation of the preload condition of the fetus by inferior vena caval blood flow pattern. Fetal Diagn Ther 1990; 5:168.</a></li><li><a class="nounderline abstract_t">Weiner CP. Umbilical pressure measurement in the evaluation of nonimmune hydrops fetalis. Am J Obstet Gynecol 1993; 168:817.</a></li><li><a class="nounderline abstract_t">Chiba Y, Kobayashi H, Kanzaki T, Murakami M. Quantitative analysis of cardiac function in non-immunological hydrops fetalis. Fetal Diagn Ther 1990; 5:175.</a></li><li><a class="nounderline abstract_t">Knilans TK. Cardiac abnormalities associated with hydrops fetalis. Semin Perinatol 1995; 19:483.</a></li><li><a class="nounderline abstract_t">Henrich W, Fuchs I, Bührer C, et al. Isolated cardiomegaly in the second trimester as an early sign of fetal hydrops due to intracranial arteriovenous malformation. J Clin Ultrasound 2003; 31:445.</a></li><li><a class="nounderline abstract_t">Jaeggi ET, Hornberger LK, Smallhorn JF, Fouron JC. Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature. Ultrasound Obstet Gynecol 2005; 26:16.</a></li><li><a class="nounderline abstract_t">Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998; 79:576.</a></li><li><a class="nounderline abstract_t">Hayakawa M, Oshiro M, Mimura S, et al. Twin-to-twin transfusion syndrome with hydrops: a retrospective analysis of ten cases. Am J Perinatol 1999; 16:263.</a></li><li><a class="nounderline abstract_t">Matsuda Y, Kouno S. Fetal and neonatal outcomes in twin oligohydramnios-polyhydramnios sequence including cerebral palsy. Fetal Diagn Ther 2002; 17:268.</a></li><li><a class="nounderline abstract_t">Blair DK, Vander Straten MC, Gest AL. Hydrops in fetal sheep from rapid induction of anemia. Pediatr Res 1994; 35:560.</a></li><li><a class="nounderline abstract_t">Moise KJ Jr, Carpenter RJ Jr, Hesketh DE. Do abnormal Starling forces cause fetal hydrops in red blood cell alloimmunization? Am J Obstet Gynecol 1992; 167:907.</a></li><li><a class="nounderline abstract_t">Ierullo AM, Ganapathy R, Crowley S, et al. Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations. Ultrasound Obstet Gynecol 2005; 26:150.</a></li><li><a class="nounderline abstract_t">Golladay ES, Mollitt DL. Surgically correctable fetal hydrops. J Pediatr Surg 1984; 19:59.</a></li><li><a class="nounderline abstract_t">Lim FY, Crombleholme TM, Hedrick HL, et al. Congenital high airway obstruction syndrome: natural history and management. J Pediatr Surg 2003; 38:940.</a></li><li><a class="nounderline abstract_t">Rice HE, Estes JM, Hedrick MH, et al. Congenital cystic adenomatoid malformation: a sheep model of fetal hydrops. J Pediatr Surg 1994; 29:692.</a></li><li><a class="nounderline abstract_t">Wesolowski A, Piazza A. A case of mediastinal teratoma as a cause of nonimmune hydrops fetalis, and literature review. Am J Perinatol 2008; 25:507.</a></li><li><a class="nounderline abstract_t">Tanriverdi HA, Ertan AK, Hendrik HJ, et al. Outcome of cystic hygroma in fetuses with normal karyotypes depends on associated findings. Eur J Obstet Gynecol Reprod Biol 2005; 118:40.</a></li><li><a class="nounderline abstract_t">Bellini C, Mazzella M, Arioni C, et al. Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia. Am J Med Genet A 2003; 120A:92.</a></li><li><a class="nounderline abstract_t">Daniel-Spiegel E, Ghalamkarpour A, Spiegel R, et al. Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema. Prenat Diagn 2005; 25:1015.</a></li><li><a class="nounderline abstract_t">Bellini C, Hennekam RC, Boccardo F, et al. Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia. Am J Med Genet A 2006; 140:678.</a></li><li><a class="nounderline abstract_t">Basgul A, Güdücü N, Kavak ZN, et al. Three fetuses karyotyped as Turner syndrome with cystic hygroma developing hydrops: prognosis and outcome. Clin Exp Obstet Gynecol 2007; 34:182.</a></li><li><a class="nounderline abstract_t">Moïse AA, Gest AL, Weickmann PH, McMicken HW. Reduction in plasma protein does not affect body water content in fetal sheep. Pediatr Res 1991; 29:623.</a></li><li><a class="nounderline abstract_t">O'Connell AE, Boyce AC, Lumbers ER, Gibson KJ. The effects of asphyxia on renal function in fetal sheep at midgestation. J Physiol 2003; 552:933.</a></li><li><a class="nounderline abstract_t">Lumbers ER, Gunn AJ, Zhang DY, et al. Nonimmune hydrops fetalis and activation of the renin-angiotensin system after asphyxia in preterm fetal sheep. Am J Physiol Regul Integr Comp Physiol 2001; 280:R1045.</a></li><li><a class="nounderline abstract_t">De Groot CJ, Oepkes D, Egberts J, Kanhai HH. Evidence of endothelium involvement in the pathophysiology of hydrops fetalis? Early Hum Dev 2000; 57:205.</a></li><li class="breakAll">Gidday JM, Park TS, Shah AR, Gonzales ER. Modulation of basal and postischemic leukocyte-endothelial adherence by nitric oxide. Stroke 1998; 29:1423; discussion 1429-30.</li><li><a class="nounderline abstract_t">Russell RT, Carlin A, Ashworth M, Welch CR. Diffuse placental chorioangiomatosis and fetal hydrops. Fetal Diagn Ther 2007; 22:183.</a></li><li><a class="nounderline abstract_t">Barton JR, Thorpe EM Jr, Shaver DC, et al. Nonimmune hydrops fetalis associated with maternal infection with syphilis. Am J Obstet Gynecol 1992; 167:56.</a></li><li><a class="nounderline abstract_t">Sparks TN, Thao K, Lianoglou BR, et al. Nonimmune hydrops fetalis: identifying the underlying genetic etiology. Genet Med 2019; 21:1339.</a></li><li><a class="nounderline abstract_t">Gilby DM, Mee JB, Kamlin COF, et al. Outcomes following antenatal identification of hydrops fetalis: a single-centre experience from 2001 to 2012. Arch Dis Child Fetal Neonatal Ed 2019; 104:F253.</a></li><li><a class="nounderline abstract_t">Rose CH, Bofill JA, Le M, Martin RW. Non-immune hydrops fetalis: prenatal diagnosis and perinatal outcomes. J Miss State Med Assoc 2005; 46:99.</a></li><li><a class="nounderline abstract_t">Nakayama H, Kukita J, Hikino S, et al. Long-term outcome of 51 liveborn neonates with non-immune hydrops fetalis. Acta Paediatr 1999; 88:24.</a></li><li><a class="nounderline abstract_t">Ota S, Sahara J, Mabuchi A, et al. Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis. J Obstet Gynaecol Res 2016; 42:385.</a></li></ol></div><div id="topicVersionRevision">Topic 5027 Version 25.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28533037" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis-Insights from a Population-Based Dataset.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4911699" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Non-immunological hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17606565" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Hydrops fetalis: a retrospective review of cases reported to a large national database and identification of risk factors associated with death.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32212385" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Clinical characteristics and neonatal outcomes of liveborn newborns with hydrops fetalis treated in a tertiary level neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25712632" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Etiology of non-immune hydrops fetalis: An update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16010481" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Nonimmune hydrops fetalis in the liveborn: series of 32 autopsies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9481059" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Etiology and outcome of hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17361085" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Nonimmune hydrops fetalis diagnosed during the second half of pregnancy in Southern China.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17195148" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Prognostic factors and clinical features in liveborn neonates with hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1480461" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The effect of outflow pressure upon thoracic duct lymph flow rate in fetal sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8297943" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Thoracic duct lymph flow in fetal sheep with increased venous pressure from electrically induced tachycardia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2130842" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Evaluation of the preload condition of the fetus by inferior vena caval blood flow pattern.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8456887" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Umbilical pressure measurement in the evaluation of nonimmune hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2130843" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Quantitative analysis of cardiac function in non-immunological hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8822332" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cardiac abnormalities associated with hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14528445" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Isolated cardiomegaly in the second trimester as an early sign of fetal hydrops due to intracranial arteriovenous malformation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15937969" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: combined experience of two tertiary care centers and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10078084" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Fetal tachycardias: management and outcome of 127 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10586978" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Twin-to-twin transfusion syndrome with hydrops: a retrospective analysis of ten cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12169809" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Fetal and neonatal outcomes in twin oligohydramnios-polyhydramnios sequence including cerebral palsy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8065838" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hydrops in fetal sheep from rapid induction of anemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1415424" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Do abnormal Starling forces cause fetal hydrops in red blood cell alloimmunization?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16038013" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Neonatal outcome of antenatally diagnosed congenital cystic adenomatoid malformations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6366180" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Surgically correctable fetal hydrops.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12778398" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Congenital high airway obstruction syndrome: natural history and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8035286" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Congenital cystic adenomatoid malformation: a sheep model of fetal hydrops.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18756428" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A case of mediastinal teratoma as a cause of nonimmune hydrops fetalis, and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15596271" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Outcome of cystic hygroma in fetuses with normal karyotypes depends on associated findings.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12794699" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Hennekam syndrome presenting as nonimmune hydrops fetalis, congenital chylothorax, and congenital pulmonary lymphangiectasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16231305" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Hydrops fetalis: an unusual prenatal presentation of hereditary congenital lymphedema.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16502426" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Nonimmune idiopathic hydrops fetalis and congenital lymphatic dysplasia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17937097" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Three fetuses karyotyped as Turner syndrome with cystic hygroma developing hydrops: prognosis and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1866221" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Reduction in plasma protein does not affect body water content in fetal sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12937284" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The effects of asphyxia on renal function in fetal sheep at midgestation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11247826" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Nonimmune hydrops fetalis and activation of the renin-angiotensin system after asphyxia in preterm fetal sheep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10742610" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Evidence of endothelium involvement in the pathophysiology of hydrops fetalis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10742610" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Evidence of endothelium involvement in the pathophysiology of hydrops fetalis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17228155" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Diffuse placental chorioangiomatosis and fetal hydrops.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1442955" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Nonimmune hydrops fetalis associated with maternal infection with syphilis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30410095" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Nonimmune hydrops fetalis: identifying the underlying genetic etiology.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29769237" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Outcomes following antenatal identification of hydrops fetalis: a single-centre experience from 2001 to 2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15895940" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Non-immune hydrops fetalis: prenatal diagnosis and perinatal outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10090542" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Long-term outcome of 51 liveborn neonates with non-immune hydrops fetalis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26712114" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Perinatal and one-year outcomes of non-immune hydrops fetalis by etiology and age at diagnosis.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
